Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Influence of Water Intake and Balance on Body Composition in Healthy Young Adults from Spain.

Laja García AI, Moráis-Moreno C, Samaniego-Vaesken ML, Puga AM, Partearroyo T, Varela-Moreiras G.

Nutrients. 2019 Aug 15;11(8). pii: E1923. doi: 10.3390/nu11081923.

2.

Effects of Drugs and Excipients on Hydration Status.

Puga AM, Lopez-Oliva S, Trives C, Partearroyo T, Varela-Moreiras G.

Nutrients. 2019 Mar 20;11(3). pii: E669. doi: 10.3390/nu11030669. Review.

3.

Interplay between Nutrition and Hearing Loss: State of Art.

Puga AM, Pajares MA, Varela-Moreiras G, Partearroyo T.

Nutrients. 2018 Dec 24;11(1). pii: E35. doi: 10.3390/nu11010035. Review.

4.

Additive manufacturing of scaffolds with dexamethasone controlled release for enhanced bone regeneration.

Costa PF, Puga AM, Díaz-Gomez L, Concheiro A, Busch DH, Alvarez-Lorenzo C.

Int J Pharm. 2015 Dec 30;496(2):541-50. doi: 10.1016/j.ijpharm.2015.10.055. Epub 2015 Oct 28.

PMID:
26520408
5.

Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV.

Nichols SL, Bethel J, Kapogiannis BG, Li T, Woods SP, Patton ED, Ren W, Thornton SE, Major-Wilson HO, Puga AM, Sleasman JW, Rudy BJ, Wilson CM, Garvie PA; Adolescent Medicine Trials Network for HIV/AIDS Interventions.

J Neurovirol. 2016 Apr;22(2):218-30. doi: 10.1007/s13365-015-0389-0. Epub 2015 Oct 13.

6.

Effect of cytomegalovirus co-infection on normalization of selected T-cell subsets in children with perinatally acquired HIV infection treated with combination antiretroviral therapy.

Kapetanovic S, Aaron L, Montepiedra G, Anthony P, Thuvamontolrat K, Pahwa S, Burchett S, Weinberg A, Kovacs A; Pediatric AIDS Clinical Trials Group Protocol 366.

PLoS One. 2015 Mar 20;10(3):e0120474. doi: 10.1371/journal.pone.0120474. eCollection 2015.

7.

Osteogenic poly(ε-caprolactone)/poloxamine homogeneous blends prepared by supercritical foaming.

de Matos MB, Puga AM, Alvarez-Lorenzo C, Concheiro A, Braga ME, de Sousa HC.

Int J Pharm. 2015 Feb 1;479(1):11-22. doi: 10.1016/j.ijpharm.2014.12.041. Epub 2014 Dec 23.

PMID:
25541145
8.

Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020A.

Rutstein RM, Samson P, Fenton T, Fletcher CV, Kiser JJ, Mofenson LM, Smith E, Graham B, Mathew M, Aldrovani G; PACTG 1020A Study Team.

Pediatr Infect Dis J. 2015 Feb;34(2):162-7. doi: 10.1097/INF.0000000000000538.

9.

Predictors of resolution and persistence of renal laboratory abnormalities in pediatric HIV infection.

Mitchell CD, Chernoff MC, Seage GR 3rd, Purswani MU, Spiegel HM, Zilleruelo G, Abitbol C, Heckman B, Ponce CB, Oleske JM; IMPAACT 219/219C Study Team.

Pediatr Nephrol. 2015 Jan;30(1):153-65. doi: 10.1007/s00467-014-2909-1. Epub 2014 Aug 24.

10.

Materials with fungi-bioinspired surface for efficient binding and fungi-sensitive release of antifungal agents.

Segura T, Puga AM, Burillo G, Llovo J, Brackman G, Coenye T, Concheiro A, Alvarez-Lorenzo C.

Biomacromolecules. 2014 May 12;15(5):1860-70. doi: 10.1021/bm500257s. Epub 2014 Apr 21.

PMID:
24712760
11.

Pectin-coated chitosan microgels crosslinked on superhydrophobic surfaces for 5-fluorouracil encapsulation.

Puga AM, Lima AC, Mano JF, Concheiro A, Alvarez-Lorenzo C.

Carbohydr Polym. 2013 Oct 15;98(1):331-40. doi: 10.1016/j.carbpol.2013.05.091. Epub 2013 Jun 7.

PMID:
23987352
12.

Crosslinked ionic polysaccharides for stimuli-sensitive drug delivery.

Alvarez-Lorenzo C, Blanco-Fernandez B, Puga AM, Concheiro A.

Adv Drug Deliv Rev. 2013 Aug;65(9):1148-71. doi: 10.1016/j.addr.2013.04.016. Epub 2013 Apr 29. Review.

PMID:
23639519
13.

End-group rearrangements in poly(propylene sulfide) matrix-assisted laser desorption/ionization time-of-flight analysis. Experimental evidence and possible mechanisms.

Lallana E, Ferreri T, Carroccio SC, Puga AM, Tirelli N.

Rapid Commun Mass Spectrom. 2012 Sep 30;26(18):2158-64. doi: 10.1002/rcm.6337.

PMID:
22886812
14.

The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1.

Patel K, Van Dyke RB, Mittleman MA, Colan SD, Oleske JM, Seage GR 3rd; International Maternal Pediatric Adolescent AIDS Clinical Trials 219219C Study Team.

AIDS. 2012 Oct 23;26(16):2027-37. doi: 10.1097/QAD.0b013e3283578bfa.

15.

Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus.

Lujan-Zilbermann J, Warshaw MG, Williams PL, Spector SA, Decker MD, Abzug MJ, Heckman B, Manzella A, Kabat B, Jean-Philippe P, Nachman S, Siberry GK; International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1065 Protocol Team.

J Pediatr. 2012 Oct;161(4):676-81.e2. doi: 10.1016/j.jpeds.2012.04.005. Epub 2012 May 22.

16.

Hot melt poly-ε-caprolactone/poloxamine implantable matrices for sustained delivery of ciprofloxacin.

Puga AM, Rey-Rico A, Magariños B, Alvarez-Lorenzo C, Concheiro A.

Acta Biomater. 2012 Apr;8(4):1507-18. doi: 10.1016/j.actbio.2011.12.020. Epub 2011 Dec 17.

PMID:
22251935
17.

Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial.

Currier J, Averitt Bridge D, Hagins D, Zorrilla CD, Feinberg J, Ryan R, Falcon R, Tennenberg A, Mrus J, Squires K; GRACE (Gender, Race, And Clinical Experience) Study Group.

Ann Intern Med. 2010 Sep 21;153(6):349-57. doi: 10.7326/0003-4819-153-6-201009210-00002.

18.

Mode of delivery and infant respiratory morbidity among infants born to HIV-1-infected women.

Livingston EG, Huo Y, Patel K, Brogly SB, Tuomala R, Scott GB, Bardeguez A, Stek A, Read JS; International Maternal Pediatric Adolescent AIDS Clinical Trials Group Protocol 1025 Study Team.

Obstet Gynecol. 2010 Aug;116(2 Pt 1):335-43. doi: 10.1097/AOG.0b013e3181e8f38a.

19.

Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents.

Siberry GK, Williams PL, Lujan-Zilbermann J, Warshaw MG, Spector SA, Decker MD, Heckman BE, Demske EF, Read JS, Jean-Philippe P, Kabat W, Nachman S; IMPAACT P1065 Protocol Team.

Pediatr Infect Dis J. 2010 May;29(5):391-6. doi: 10.1097/INF.0b013e3181c38f3b.

20.

Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents.

Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR 3rd; International Maternal Pediatric Adolescent AIDS Clinical Trials 219/219C Study Team.

AIDS. 2009 Sep 10;23(14):1893-901. doi: 10.1097/QAD.0b013e32832dc041.

Supplemental Content

Loading ...
Support Center